FDA DEVICE FACTS
CD Horizon™ ModuLeX™ Spinal System (LigaMAS Head Assembly)
Medtronic Sofamor Danek USA, Inc.
Verified FDA Record identity for medical-device development research. This overview uses only fields stated in the FDA Record and is not a Device Description.医療機器開発の調査用に、確認済みの FDA Record の識別情報を示しています。この概要は FDA Record に記載された項目だけによるもので、機器説明ではありません。
Indications for use
| V. Indications for Use | CD Horizon™ Spinal System The CD Horizon™ Spinal System with or without Sextant™ instrumentation is intended for posterior, non-cervical fixation as an adjunct to fusion for the following indications: degenerative disc disease (DDD - defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies), spondylolisthesis, trauma (i.e. fracture or dislocation), spinal stenosis, curvatures (i.e. scoliosis, kyphosis, or lordosis), tumor, pseudarthrosis, and/or failed previous fusion. |
hooks, when used as an anterolateral thoracic/lumbar system, the CD Horizon™ Spinal System titanium, cobalt chrome, and stainless- steel implants may also be used for the same indications as an adjunct to fusion. With the exception of DDD, CD Horizon™ Legacy™ 3.5mm rods and associated components may be used for indications in skeletally mature patients as an adjunct to fusion. The 3.5mm rods may be used for the specific pediatric indications noted. When used for posterior non- cervical pedicle screw fixation in pediatric patients, CD Horizon™ Spinal System titanium, cobalt chrome, and stainless-steel implants are indicated as an adjunct to fusion to treat progressive spinal deformities (i.e. scoliosis, kyphosis, or lordosis) including idiopathic scoliosis, neuromuscular scoliosis, and congenital scoliosis. Additionally, the CD Horizon™ Spinal System is intended to treat pediatric patients diagnosed with the following conditions: spondylolisthesis/spondylolysis, fracture caused by tumor and/or trauma, pseudarthrosis, and/or failed previous fusion. These devices are to be used with autograft and/or allograft. Pediatric pedicle screw fixation is limited to a posterior approach. The CD Horizon ™ PEEK rods are intended to provide posterior supplemental fixation when used with an interbody fusion cage for patients diagnosed with DDD. These DDD patients may also have up to Grade 1 spondylolisthesis or retrolisthesis at the involved level. This devic e is intended for 1- 2 level use in the lumbosacral spine (L2 – S1) in skeletally mature patients. Devices are intended for use with an interbody fusion cage at the instrumented level and is not intended for stand-alone use. The CD Horizon ™ Spire™ plate is a posterior, single -level, non-pedicle supplemental fixation device intended for use in the non-cervical spine (T1-S1) as an adjunct to fusion in skeletally mature patients. It is intended for plate fixation/attachment to spinous processes for the purpose of achieving supplemental fixation in the following conditions: DDD, spondylolisthesis, trauma, and/or tumor. To achieve additional levels of fixation, CD Horizon™ Spinal System rods may be connected to the Vertex ™ Reconstruction System with the Vertex ™ rod connector. Refer to the Vertex™
Reconstruction System package insert for a list of Vertex ™ indications for use. The CD Horizon™ LigaMAS Head Assembly used with the LigaPASS™ Spinal System is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. The indications for use include the following applications:
• Spinal trauma, used in sublaminar, or facet wiring techniques
• Spinal reconstruction surgery, incorporated into constructs for the purpose of correction of spinal deformities such as idiopathic and neuromuscular scoliosis in patients 8 years of age and older, adult scoliosis, and kyphosis;
• Spinal degenerative surgery, as an adjunct to spinal fusions.
| Reconstruction System package insert for a list of Vertex™ indications for use. The CD Horizon™ LigaMAS Head Assembly used with the LigaPASS™ Spinal System is intended to provide temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. The indications for use include the following applications: • Spinal trauma, used in sublaminar, or facet wiring techniques • Spinal reconstruction surgery, incorporated into constructs for the purpose of correction of spinal deformities such as idiopathic and neuromuscular scoliosis in patients 8 years of age and older, adult scoliosis, and kyphosis; • Spinal degenerative surgery, as an adjunct to spinal fusions. | |
| VI. Comparison of Technological Characteristics with the Predicate Devices | The subject devices have the same intended use, indications for use, materials, similar overall design, fundamental technology, sterilization, as the following predicates: • K221244 (S.E. 05/25/2022) • K172021 (S.E. 08/30/2017) The subject and predicate implants have the same function and fundamental scientific technology. |
| VII. Performance Data | In accordance with the Guidance for Industry and FDA Staff – Spinal System 510(k)’s, Medtronic has evaluated the subject device to demonstrate substantial equivalence to the predicates. The subject device has been tested or rationalized based on if Medtronic believes that testing is not warranted for the subject device as it does not present a new worst case when compared to the predicates. Testing and/or Rationales were completed for the following: • ASTM F1717: Static Compression, Static Torsion, Compression Fatigue |
| • ASTM F1798:Axial Grip, Axial Torsion, Flexion Extension Static, Flexion Extension Fatigue • Static and Fatigue • ASTM F2503: MRI Compatibility Evaluation For the completed subject testing, the pre-determined acceptance criteria was met for all tests. For the subject testing that is rationalized, all existing predicate data previously provided in the predicate 510(k)s is still applicable. Therefore, Medtronic believes the design verification testing demonstrated that the subject device is substantially equivalent to the predicates. | |
| VIII. Conclusion | Based on the supporting evidence provided in this premarket notification, Medtronic believes the subject device is substantially equivalent to the predicates listed above. |
Tables marked from the FDA document were reconstructed automatically. Check the original FDA document (links at the end of this page) for authoritative values.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。